يعرض 1 - 10 نتائج من 346 نتيجة بحث عن '"Sonpavde G."', وقت الاستعلام: 0.96s تنقيح النتائج
  1. 1
    دورية أكاديمية
    PP01.50 EMERGE-201: Phase 2 Basket Study of Lurbinectedin Monotherapy in Advanced or Metastatic Solid Tumors

    المؤلفون: Spigel, D., Galsky, M.D., Heeke, A.L., Villaruz, L.C., Sands, J., Subbiah, V., Sonpavde, G., Singh, A.P., Srinivas, S., Brock, G., Cai, G., Bhatt, K., Chakrabarti, D.

    المصدر: Journal of Thoracic Oncology ; volume 18, issue 3, page e31 ; ISSN 1556-0864

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology

    الإتاحة: https://doi.org/10.1016/j.jtho.2022.09.076Test
    https://api.elsevier.com/content/article/PII:S1556086422016628?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S1556086422016628?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.

    المؤلفون: van der Heijden, M. S.1 mstd.heijden@nki.nl, Sonpavde, G.2, Powles, T.3, Necchi, A.4, Burotto, M.5, Schenker, M.6, Sade, J. P.7, Bamias, A.8, Beuzeboc, P.9, Bedke, J.10, Oldenburg, J.11, Chatta, G.12, Örön, Y.13, Ye, D.14, He, Z.15, Valderrama, B. P.16, Ku, J. H.17, Tomita, Y.18, Filian, J.19, Wang, L.19

    المصدر: New England Journal of Medicine. 11/9/2023, Vol. 389 Issue 19, p1778-1789. 12p.

    مصطلحات موضوعية: *TRANSITIONAL cell carcinoma, *NIVOLUMAB, *PROGRESSION-free survival, *SURVIVAL rate, *OVERALL survival


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Genomic Features of Radiation-Associated Muscle-Invasive Bladder Cancer

    المؤلفون: Muralidhar, V., Carvalho, F., Preston, M., Curran, C., Freeman, D., Sonpavde, G., Kibel, A., Van Allen, E.M., Mossanen, M., Mouw, K.W.

    المصدر: International Journal of Radiation Oncology*Biology*Physics ; volume 111, issue 3, page S13-S14 ; ISSN 0360-3016

    مصطلحات موضوعية: Cancer Research, Radiology, Nuclear Medicine and imaging, Oncology, Radiation

    الإتاحة: https://doi.org/10.1016/j.ijrobp.2021.07.062Test
    https://api.elsevier.com/content/article/PII:S0360301621009329?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0360301621009329?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    A phase 2 study of futibatinib plus pembrolizumab in patients (pts) with advanced or metastatic urothelial carcinoma (mUC)

    المؤلفون: Sonpavde, G., Koshkin, V.S., Hwang, C., Mellado, B., Tomlinson, G., Shimura, M., Chisamore, M.J., Gil, M., Loriot, Y.

    المصدر: European Urology Open Science ; volume 33, page S383-S384 ; ISSN 2666-1683

    مصطلحات موضوعية: Urology

    الإتاحة: https://doi.org/10.1016/s2666-1683Test(21)03206-7
    https://api.elsevier.com/content/article/PII:S2666168321032067?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2666168321032067?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone

    المؤلفون: Crocetto F., Ferro M., Buonerba C., Bardi L., Dolce P., Scafuri L., Mirto B. F., Verde A., Sciarra A., Barone B., Calogero A., Sagnelli C., Busetto G. M., Del Giudice F., Cilio S., Sonpavde G., Di Trolio R., Della Ratta G. L., Barbato G., Di Lorenzo G.

    المساهمون: Crocetto, F., Ferro, M., Buonerba, C., Bardi, L., Dolce, P., Scafuri, L., Mirto, B. F., Verde, A., Sciarra, A., Barone, B., Calogero, A., Sagnelli, C., Busetto, G. M., Del Giudice, F., Cilio, S., Sonpavde, G., Di Trolio, R., Della Ratta, G. L., Barbato, G., Di Lorenzo, G.

    مصطلحات موضوعية: Angiogenesis inhibitor, Cardiovascular toxicity, Immune checkpoint inhibitors

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:001054479500001; volume:188; firstpage:104059; journal:CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; https://hdl.handle.net/11588/952887Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85164993086

    الإتاحة: https://doi.org/10.1016/j.critrevonc.2023.104059Test
    https://hdl.handle.net/11588/952887Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis

    المؤلفون: Ferro M., Crocetto F., Tataru S., Barone B., Dolce P., Lucarelli G., Sonpavde G., Musi G., Antonelli A., Veccia A., Terracciano D., Busetto G. M., Del Giudice F., Marchioni M., Schips L., Porpiglia F., Fiori C., Carrieri G., Lasorsa F., Verde A., Scafuri L., Buonerba C., Di Lorenzo G.

    المساهمون: Ferro, M., Crocetto, F., Tataru, S., Barone, B., Dolce, P., Lucarelli, G., Sonpavde, G., Musi, G., Antonelli, A., Veccia, A., Terracciano, D., Busetto, G. M., Del Giudice, F., Marchioni, M., Schips, L., Porpiglia, F., Fiori, C., Carrieri, G., Lasorsa, F., Verde, A., Scafuri, L., Buonerba, C., Di Lorenzo, G.

    مصطلحات موضوعية: Bladder cancer, Chemotherapy, Immunotherapy, Metastasi, Visceral metastasis

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:001086166100001; volume:21; issue:5; firstpage:574; lastpage:583; numberofpages:10; journal:CLINICAL GENITOURINARY CANCER; https://hdl.handle.net/11588/952885Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85164575455

    الإتاحة: https://doi.org/10.1016/j.clgc.2023.05.017Test
    https://hdl.handle.net/11588/952885Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    799TiP PROOF 302: A randomized, double-blind, placebo-controlled, phase III trial of infigratinib as adjuvant therapy in patients with invasive urothelial carcinoma harboring susceptible FGFR3 alterations

    المؤلفون: Somford, D.M., Daneshmand, S., Grivas, P., Sridhar, S., Gupta, S., Bellmunt, J., Sonpavde, G., Fleming, M.T., Lerner, S.P., Loriot, Y., Li, A., Takkele, H., Andresen, C., Rearden, J., Peacock Shepherd, S., Schnabel, M.J., Pal, S.K.

    المصدر: Annals of Oncology ; volume 31, page S606 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/j.annonc.2020.08.2070Test
    https://api.elsevier.com/content/article/PII:S0923753420420678?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753420420678?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    783P Real-world outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) who received first- (1L) or second-line (2L) PD-1 and PD-L1 inhibitors in the United States (US)

    المؤلفون: Boyd, M., Annavarapu, S., Doshi, G.K., Imai, K., Sbar, E.I., Godwin, J.L., Li, H., Sonpavde, G.

    المصدر: Annals of Oncology ; volume 31, page S599 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/j.annonc.2020.08.855Test
    https://api.elsevier.com/content/article/PII:S0923753420408518?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753420408518?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Identifying immune-related biomarkers to predict clinical outcomes of neoadjuvant immuno-chemotherapy (nivolumab, gemcitabine and cisplatin) in muscle-invasive bladder cancer (NCT03294304)

    المؤلفون: Eckstein, M., Konety, B., Weight, C., Sonpavde, G., Gupta, S., Maughan, B., Gibb, E., Davicioni, E., Paari, M., Thyagarajan, B., Neeraj, A.

    المصدر: European Urology Open Science ; volume 19, page e201 ; ISSN 2666-1683

    مصطلحات موضوعية: Urology

    الإتاحة: https://doi.org/10.1016/s2666-1683Test(20)32683-5
    https://api.elsevier.com/content/article/PII:S2666168320326835?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2666168320326835?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    EV-301: A phase III trial in progress evaluating enfortumab vedotin versus chemotherapy in patients with locally advanced or metastatic urothelial carcinoma

    المؤلفون: Petrylak, D.P., Rosenberg, J.E., Lee, J., Yonese, J., Duran, I., Loriot, Y., Sonpavde, G., Wu, C., Gartner, E.M., Melhem-Bertrandt, A., Powles, T.

    المصدر: Annals of Oncology ; volume 30, page ix75-ix76 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1093/annonc/mdz425.014Test
    https://api.elsevier.com/content/article/PII:S0923753419578991?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753419578991?httpAccept=text/plainTest
    http://academic.oup.com/annonc/article-pdf/30/Supplement_9/mdz425.014/31093384/mdz425.014.pdfTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث